{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T16:34:06Z","timestamp":1786120446403,"version":"build-2736575974"},"publisher-location":"New York, NY","reference-count":16,"publisher":"Springer US","isbn-type":[{"value":"9781071651896","type":"print"},{"value":"9781071651902","type":"electronic"}],"license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026]]},"DOI":"10.1007\/978-1-0716-5190-2_17","type":"book-chapter","created":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T22:03:44Z","timestamp":1786053824000},"page":"321-335","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Combined In Silico Approaches for Virtual Screening of Noncovalent Immunoproteasome Inhibitors for Multiple Myeloma Treatment"],"prefix":"10.1007","author":[{"given":"Giulia","family":"Culletta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Sohaib","family":"Roomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Tutone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,2]]},"reference":[{"key":"17_CR1","doi-asserted-by":"publisher","unstructured":"Tutone M, Almerico AM (2021) Computational approaches: drug discovery and design in medicinal chemistry and bioinformatics. Molecules 26(24):7500. https:\/\/doi.org\/10.3390\/molecules26247500","DOI":"10.3390\/molecules26247500"},{"key":"17_CR2","doi-asserted-by":"publisher","unstructured":"Angeles A, Fung G, Luo H (2012) Immune and non-immune functions of the immunoproteasome. Front Biosci 17:1904\u20131916. https:\/\/doi.org\/10.2741\/4027","DOI":"10.2741\/4027"},{"key":"17_CR3","doi-asserted-by":"publisher","unstructured":"Kuhn DJ, Orlowski RZ (2012) The immunoproteasome as a target in hematologic malignancies. Semin Hematol 49(3):258\u2013262. https:\/\/doi.org\/10.1053\/j.seminhematol.2012.04.003","DOI":"10.1053\/j.seminhematol.2012.04.003"},{"key":"17_CR4","doi-asserted-by":"publisher","unstructured":"Xi J, Zhuang R, Kong L, He R, Zhu H, Zhang J (2019) Immunoproteasome-selective inhibitors: an overview of recent developments as potential drugs for hematologic malignancies and autoimmune diseases. Eur J Med Chem 182:111646. https:\/\/doi.org\/10.1016\/j.ejmech.2019.111646","DOI":"10.1016\/j.ejmech.2019.111646"},{"key":"17_CR5","doi-asserted-by":"publisher","unstructured":"Ghosh AK, Samanta I, Mondal A, Liu WR (2019) Covalent inhibition in drug discovery. ChemMedChem 14(9):889\u2013906. https:\/\/doi.org\/10.1002\/cmdc.201900107","DOI":"10.1002\/cmdc.201900107"},{"key":"17_CR6","doi-asserted-by":"publisher","unstructured":"Culletta G, Zappal\u00e0 M, Ettari R, Almerico AM, Tutone M (2021) Immunoproteasome and non-covalent inhibition: exploration by advanced molecular dynamics and docking methods. Molecules 26(13):4046. https:\/\/doi.org\/10.3390\/molecules26134046","DOI":"10.3390\/molecules26134046"},{"key":"17_CR7","doi-asserted-by":"publisher","unstructured":"Zhan W, Singh PK, Ban Y et al (2020) Structure-activity relationships of noncovalent immunoproteasome \u03b25i-selective dipeptides. J Med Chem 63(23):14257\u201314275. https:\/\/doi.org\/10.1021\/acs.jmedchem.0c01520","DOI":"10.1021\/acs.jmedchem.0c01520"},{"key":"17_CR8","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1007\/s10822-013-9644-8","volume":"27","author":"G Madhavi Sastry","year":"2013","unstructured":"Madhavi Sastry G, Adzhigirey M, Day T, Annabhimoju R, Sherman W (2013) Protein and ligand preparation: parameters, protocols, and influence on virtual screening enrichments. J Comput Aided Mol Des 27:221\u2013234. https:\/\/doi.org\/10.1007\/s10822-013-9644-8","journal-title":"J Comput Aided Mol Des"},{"key":"17_CR9","doi-asserted-by":"publisher","unstructured":"Decherchi S, Bottegoni G, Spitaleri A, Rocchia W, Cavalli A (2018) BiKi life sciences: a new suite for molecular dynamics and related methods in drug discovery. J Chem Inf Model 58(2):219\u2013224. https:\/\/doi.org\/10.1021\/acs.jcim.7b00680","DOI":"10.1021\/acs.jcim.7b00680"},{"key":"17_CR10","doi-asserted-by":"publisher","unstructured":"Wolber G, Langer T (2005) LigandScout: 3-D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. J Chem Inf Model 45(1):160\u2013169. https:\/\/doi.org\/10.1021\/ci049885e","DOI":"10.1021\/ci049885e"},{"key":"17_CR11","doi-asserted-by":"publisher","unstructured":"Culletta G, Tutone M, Ettari R, Perricone U, Di Chio C, Almerico AM, Zappal\u00e0 M (2023) Virtual screening strategy and in vitro tests to identify new inhibitors of the immunoproteasome. Int J Mol Sci 24(13):10504. https:\/\/doi.org\/10.3390\/ijms241310504","DOI":"10.3390\/ijms241310504"},{"key":"17_CR12","doi-asserted-by":"publisher","first-page":"77","DOI":"10.3390\/computation8030077","volume":"8","author":"G Culletta","year":"2020","unstructured":"Culletta G, Gulotta MR, Perricone U, Zappal\u00e0 M, Almerico AM, Tutone M (2020) Exploring the SARS-CoV-2 proteome in the search of potential inhibitors via structure-based pharmacophore modeling\/docking approach. Computation 8(3):77. https:\/\/doi.org\/10.3390\/computation8030077","journal-title":"Computation"},{"key":"17_CR13","doi-asserted-by":"publisher","unstructured":"Culletta G, Almerico AM, Tutone M (2020) Comparing molecular dynamics-derived pharmacophore models with docking: a study on CDK-2 inhibitors. Chem Data Collect 29:100485. https:\/\/doi.org\/10.1016\/j.cdc.2020.100485","DOI":"10.1016\/j.cdc.2020.100485"},{"key":"17_CR14","doi-asserted-by":"publisher","unstructured":"de Carvalho Bertozo L, Tutone M, Pastrello B, da Silva-Filho LC, Culletta G, Almerico AM, Farias Ximenes V (2023) Aminoquinolines: fluorescent sensors to DNA\u2009\u2013\u2009a minor groove probe. Experimental and in silico studies. J Photochem Photobiol A Chem 439:114944. https:\/\/doi.org\/10.1016\/j.jphotochem.2023.114944","DOI":"10.1016\/j.jphotochem.2023.114944"},{"key":"17_CR15","doi-asserted-by":"publisher","unstructured":"Allegra M, Tutone M, Tesoriere L, Attanzio A, Culletta G, Almerico AM (2021) Evaluation of the IKK\u03b2 binding of indicaxanthin by induced-fit docking, binding pose metadynamics, and molecular dynamics. Front Pharmacol 12:701568. https:\/\/doi.org\/10.3389\/fphar.2021.701568","DOI":"10.3389\/fphar.2021.701568"},{"key":"17_CR16","doi-asserted-by":"publisher","unstructured":"Carollo PS, Tutone M, Culletta G et al (2023) Investigating the inhibition of FTSJ1, a tryptophan tRNA-specific 2\u2032-O-methyltransferase by NV TRIDs, as a mechanism of readthrough in nonsense mutated CFTR. Int J Mol Sci 24(11):9609. https:\/\/doi.org\/10.3390\/ijms24119609","DOI":"10.3390\/ijms24119609"}],"container-title":["Methods in Molecular Biology","Targeting Enzymes for Pharmaceutical Development"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-5190-2_17","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T22:03:45Z","timestamp":1786053825000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-5190-2_17"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026]]},"ISBN":["9781071651896","9781071651902"],"references-count":16,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-5190-2_17","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026]]},"assertion":[{"value":"2 July 2026","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"The authors have no conflicts of interest to declare that are relevant to the content of this chapter.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}